Novel Monoclonal Antibody Inhibits Tumor Growth in BC......

Options

http://www.sciencedaily.com/releases/2013/04/130419132516.htm

A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.

Categories